Calmare Therapeutics Incorporated
  • Home
  • About∨
    • Profile
    • Who We Are
    • Board of Directors
  • Services∨
    • Overview
    • Licensing
    • Technology Sourcing
  • Technologies∨
    • Featured Technologies
    • Portfolio
  • News & Press∨
    • Current
    • 2020
    • 2019
  • Investors∨
    • CTI at a Glance
    • Board of Directors
    • Who We Are
    • SEC Filings
    • Corporate Governance
    • Investor Contacts
  • Contact∨
    • Corporate Offices
    • Investor Contacts
Latest Press Releases
24 Aug 2016 Calmare Therapeutics Reports Second Quarter 2016 Results
25 May 2016 Calmare Therapeutics to Present at the 5th Annual SeeThruEquity Microcap Investor Conference
23 May 2016 Calmare Therapeutics Incorporated Uplists
19 May 2016 Calmare Therapeutics Reports First Quarter 2016 Results
5 May 2016 Calmare Therapeutics Receives Final Signatures on Supply Order Contract Documents
19 Apr 2016 Calmare Therapeutics Reports Year-End 2015 Results
2 Mar 2016 Calmare Therapeutics Reports Third Quarter 2015 Results
18 Feb 2016 Calmare Therapeutics Awarded $15 Million General Supply Order Contract
17 Feb 2016 Calmare Therapeutics Incorporated Appoints Christine Chansky, M.D., J.D., F.C.L.M., Chief Regulatory Officer

Archives

  • 2021
  • 2020
  • 2019
CTI News & Press Add the CTI News & Press RSS feed to your reader.
Sunday, August 1st 2021 Terms of Service | Privacy | Legal | Sitemap | 
Copyright Calmare Therapeutics Incorporated © 1999-2021
  • Digg
  • StumbleUpon
  • del.icio.us
  • Facebook
  • Google
  • GooglePlus
  • reddit
  • Twitter
  • Linked In